Skip to main content
. 2022 Dec 2;7:47. doi: 10.1186/s41256-022-00281-z

Table 2.

Summary of key results by theme and country

Theme Related CFIR constructs and other codes Common findings across three sites Country-specific findings
Benin India Malawi
Key facilitators for launching cMDA
Effective, tailored community sensitization is a key component of successfully launching cMDA

Engaging participants

Engaging leaders

Design quality and packaging

Intervention complexity

Strong outreach activities at baseline are particularly important for overcoming myths related to cMDA rollout Outreach activities will need to be tailored to address adults who may believe they are at low risk for STH infection

Outreach activities will need to be tailored to address adults who may believe they are at low risk for STH infection

Outreach activities should be further tailored by geography, education, and socio-economic status

Outreach messages need to be tailored to community sub-groups, such as religious groups
Opportunities to leverage existing health campaign infrastructure is important for policy stakeholders to support cMDA launch

Structural characteristics

Tension for change

Adaptability

Existing school-based and lymphatic filariasis MDA resources can be used to support the launch of cMDA including human resources and existing infrastructure cMDA for STH should be integrated within child health programs cMDA for STH should be integrated within maternal and reproductive health program objectives No additional Malawi-specific findings
Key barriers to launching cMDA
Policy stakeholders are concerned about health worker workload when implementing cMDA

Available resources

Organizational incentives

Implementation climate

Relative advantage

Intervention complexity

Readiness

Stakeholders are concerned that Community Drug Distributors (CDDs) are overworked and that increasing workload will lead to poorly delivered cMDA programs

Stakeholders believe there are not enough CDDs available to support a cMDA program

Insufficient incentives and a focus on performance-based targets are barriers to successfully launching cMDA

Supervisors may not be able to provide adequate supervision to CDDs during cMDA programs

Stakeholders suggest that the CDD workforce would need to be increased to deliver cMDA and overcome challenges including delivery to hard-to-reach places

The health workforce may not immediately accept launching cMDA if it increases their workload

Stakeholders believe there are not enough CDDs readily available to support a cMDA program

Launching cMDA would require additional monetary incentives for the involved health workforce

The CDD workforce would need to be expanded

The cMDA program would need to account for challenges including delivery in hard-to-reach areas, inadequate time to deliver, and multiple visits

Policy stakeholders are uncertain about the sustainability of cMDA programs without additional external funding

Relative priority

Available resources

Financial cost

Donor relationships

There are a limited number of donors and partners supporting NTD programs globally, which might compromise the ability to scale-up cMDA programs more broadly cMDA will not be successful in the long-term without support from donors and non-governmental organizations Financial resources were not perceived to be a major barrier due to reduced donor dependence cMDA will not be successful in the long-term without support from donors and non-governmental organizations
Concerns about existing intragovernmental partnerships are barriers to launching cMDA Cosmopolitanism No common finding across all three countries Did not highlight cross-ministry or partner coordination challenges Did not highlight cross-ministry or partner coordination challenges Stakeholders are concerned about the lack of formal information-sharing systems and supervisory structures necessary to collaborate between involved government ministries
Cross-cutting theme
Future updates to STH policy will require rigorous evidence to ensure buy-in from policy stakeholders

Knowledge and beliefs

Evidence strength and quality

Rigorous clinical and implementation evidence are needed before updating current STH policies

Policymakers had positive attitudes that cMDA could potentially eliminate STH, primarily because they believed that tools are currently available to achieve targeted endpoints

No additional Benin-specific findings No additional India-specific findings No additional Malawi-specific findings